Coherus Biosciences (CHRS) Technical (Analysis) Reports Coherus Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Coherus Biosciences (CHRS)
Technical Analysis Report for USA stock CHRS Coherus Biosciences. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CHRS Coherus Biosciences then click here. or read Experts views on Coherus Biosciences or Forecast & share price targets of Coherus Biosciences
Coherus Biosciences Opened at 1.16 and Closed at: 1.12, which is -3.57% of previous session's close. It moved within a range of 1.08 and 1.16
The session was a Bearish session with an average volume of 2009400, which is 41.12% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
Support for tomorrow is 1.06 and resistance for tomorrow is 1.14
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.08, 1.04 resistance for tomorrow's hourly charts is 1.16, 1.2
10 Day SMA for Coherus Biosciences (CHRS) is 1.18 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Coherus Biosciences (CHRS) is 1.26 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Coherus Biosciences (CHRS) is 1.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.4 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Coherus Biosciences is 1.57 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Coherus Biosciences is at 1.26 and 200 DMA is at 1.57, while 50 DMA and 100 DMA are at 1.31 and 1.4 respectively
Coherus Biosciences (CHRS) moving average of 20 SMA is at 1.26 and 20 EMA is at 1.23
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 1.12 | 1.26 | 1.23 |
| 02 Fri Oct | 1.16 | 1.27 | 1.24 |
| 01 Thu Oct | 1.16 | 1.28 | 1.25 |
| 30 Wed Sep | 1.21 | 1.3 | 1.26 |
| 29 Tue Sep | 1.18 | 1.3 | 1.27 |
| 28 Mon Sep | 1.14 | 1.31 | 1.28 |
Coherus Biosciences (CHRS) moving average of 50 SMA is at 1.31 and 50 EMA is at 1.33
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 1.12 | 1.31 | 1.33 |
| 02 Fri Oct | 1.16 | 1.32 | 1.34 |
| 01 Thu Oct | 1.16 | 1.33 | 1.35 |
| 30 Wed Sep | 1.21 | 1.33 | 1.36 |
| 29 Tue Sep | 1.18 | 1.34 | 1.37 |
| 28 Mon Sep | 1.14 | 1.34 | 1.38 |
Coherus Biosciences (CHRS) moving average of 100 SMA is at 1.4 and 100 EMA is at 1.44
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 1.12 | 1.4 | 1.44 |
| 02 Fri Oct | 1.16 | 1.41 | 1.45 |
| 01 Thu Oct | 1.16 | 1.42 | 1.46 |
| 30 Wed Sep | 1.21 | 1.42 | 1.47 |
| 29 Tue Sep | 1.18 | 1.43 | 1.48 |
| 28 Mon Sep | 1.14 | 1.43 | 1.49 |
Coherus Biosciences (CHRS) moving average of 200 SMA is at 1.57 and 200 EMA is at 1.38
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 1.12 | 1.57 | 1.38 |
| 02 Fri Oct | 1.16 | 1.57 | 1.38 |
| 01 Thu Oct | 1.16 | 1.57 | 1.38 |
| 30 Wed Sep | 1.21 | 1.57 | 1.38 |
| 29 Tue Sep | 1.18 | 1.58 | 1.38 |
| 28 Mon Sep | 1.14 | 1.58 | 1.38 |
Glaxosmithkline Plc has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 14.13% more returns!
Charles River has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Charles River, about 28.94% more returns!
Brookdale Senior has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Brookdale Senior, about 5.35% more returns!
Baxter International has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Baxter International, about 15.68% more returns!
Coherus Biosciences has performed better than Tonix Pharmaceuticals in short term. Holding Coherus Biosciences could be a better choice for now!
Tandem Diabetes has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Tandem Diabetes, about 1.35% more returns!
Siga Technologies has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Siga Technologies, about 27% more returns!
Novocure has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Novocure, about 8.46% more returns!
Coherus Biosciences has performed better than Minerva Neurosciences in short term. Holding Coherus Biosciences could be a better choice for now!
Lemaitre Vascular has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 20.01% more returns!
Livanova Plc has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Livanova Plc, about 12.96% more returns!
Kodiak Sciences has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Kodiak Sciences, about 185.74% more returns!
Kiniksa Pharmaceuticals has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 17.24% more returns!
Iovance Biotherapeutics has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 80.89% more returns!
Coherus Biosciences has performed better than Cellectis S in short term. Holding Coherus Biosciences could be a better choice for now!
Capricor Therapeutics has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 4.12% more returns!
Achieve Life has performed better than Coherus Biosciences in short term. You could have earned much better returns by investing in Achieve Life, about 7.66% more returns!
Coherus Biosciences has performed better than Aceto Corporation in short term. Holding Coherus Biosciences could be a better choice for now!
Coherus Biosciences Technical analysis of indicators
Price action analysis of Coherus Biosciences (CHRS) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Coherus Biosciences in short term and the sell signal is strong.
Coherus Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Coherus Biosciences in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Coherus Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.21 and Coherus Biosciences CHRS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences CHRS stock. Volume based technical analysis of Coherus Biosciences CHRS stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CHRS Coherus Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CHRS Experts View which covers a lot of information including buying and selling signals
CHRS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Coherus Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Coherus Biosciences (CHRS) Technical (Analysis) Reports Coherus Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


